Resources from the same session
20MO - Time to deterioration in quality of life in patients (pts) with advanced endometrial cancer (aEC) treated with lenvatinib plus pembrolizumab (L+P) or treatment of physician’s choice (TPC)
Presenter: Domenica Lorusso
Session: Mini Oral session
Resources:
Abstract
Slides
Webcast
Invited Discussant of abstract 20MO
Presenter: Jean Emmanuel Kurtz
Session: Mini Oral session
Resources:
Slides
Webcast
21MO - Limited benefit of molecular profiling in patients with low-grade endometrial cancer
Presenter: Stephanie Vrede
Session: Mini Oral session
Resources:
Abstract
Slides
Webcast
27MO - Integrated digital pathology and single-cell analysis identify the spatial and temporal evolution of immune cells networks in epithelial ovarian cancer
Presenter: Eleonora Ghisoni
Session: Mini Oral session
Resources:
Abstract
Slides
Webcast
28MO - Real-world whole sequencing data of ovarian cancer patients
Presenter: James Brenton
Session: Mini Oral session
Resources:
Abstract
Slides
Webcast
Invited Discussant of abstract 28MO
Presenter: Liselore Loverix
Session: Mini Oral session
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Jean Emmanuel Kurtz
Session: Mini Oral session
Resources:
Webcast